Compare ARK Genomic Revolution ETF (ARKG) vs JPMorgan Diversified Return International Eqty ETF (JPIN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs JPMorgan Diversified Return International Eqty ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while JPMorgan Diversified Return International Eqty ETF trades at $73.36. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, JPMorgan Diversified Return International Eqty ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | JPIN | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $76.96 |
52-Week Low | $23.09 | $63.14 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
JPIN, the JPMorgan Diversified Return International Equity ETF, trades at $73.36, up 0.67% on the day. Technical indicators are mixed, with moving averages signaling bearish sentiment while oscillators remain neutral. The ETF focuses on international large-cap value stocks, offering diversification outside the US. A dividend of $0.91 is scheduled for payment in June 2026.
The outlook for JPIN is neutral, balancing its strategic international exposure against broader market volatility. Opportunities include potential benefits from non-US value stock performance and diversification. Risks involve currency fluctuations, international economic instability, and the ETF's performance relative to US markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About JPMorgan Diversified Return International Eqty ETF
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →
